Filing Flows › Xylem (XYL) › Capital expenditures
Xylem (XYL) capital expenditures by quarter
Xylem's capital expenditures were $89.0M in Q3 2026 (third quarter 2026), 0% from Q2 2026. Over the last 7 quarters it ranged from $71.0M (Q1 2025) to $98.0M (Q2 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $89.0M | 0% | +13% |
| Q2 2026 | $89.0M | -1% | -9% |
| Q1 2026 | $90.0M | +8% | +27% |
| Q4 2025 | $83.0M | +5% | — |
| Q3 2025 | $79.0M | -19% | — |
| Q2 2025 | $98.0M | +38% | — |
| Q1 2025 | $71.0M | — | — |
Q3 2026 at a glance
Xylem, Q3 2026: revenue $2.2B (-3% year over year), operating margin 17.5%, net earnings $291M, operating cash flow $331M. The chart follows the revenue to costs, profit and cash.
Questions
What is Xylem's capital expenditures?
Xylem's capital expenditures were $89.0M in Q3 2026 (third quarter 2026), 0% from Q2 2026.
How has Xylem's capital expenditures changed?
Over the last 7 quarters it ranged from $71.0M (Q1 2025) to $98.0M (Q2 2025).